Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia

NCT00835328 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Study stopped prematurely to test a new formulation of Exendin (9-39)

Conditions

Congenital Hyperinsulinism

Interventions

DRUG: Exendin (9-39)
DRUG: Vehicle

Sponsor

Diva De Leon